In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers.
Morning Overview on MSN
Billionaires chase immortality as Harvard-backed startup wins FDA nod for 1st partial de-aging trial
The race to slow, halt, or even reverse aging has moved from science fiction into the regulatory record. A Harvard-linked ...
Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results